Accurate, balanced evidence-based information about medicines
RADAR review articles
Prolonged-release melatonin may be used short-term for primary insomnia in people aged ≥ 55 years. It improves quality of sleep and morning alertness in about one-third of patients.
Methoxyflurane provides rapid-acting short-term analgesia for use in initial management of acute trauma, via an inhaler device. To avoid renal toxicity, do not exceed maximum doses or use in people with renal impairment.
Dabigatran is an oral direct thrombin inhibitor anticoagulant. It is approved for short-term use to prevent deep vein thrombosis and pulmonary embolism after total hip or total knee replacement surgery.
In Brief

The information contained in this material is derived from a critical analysis of a wide range of authoritative evidence. Any treatment decisions based on this information should be made in the context of the clinical circumstances of each patient.